Ciwon daji na hanta

Ciwon daji na hanta
Description (en)
Iri	liver tumor (en) , liver disease (en) , rare hepatic and biliary tract tumor (en) , liver neoplasm (en) , hepatobiliary system cancer (en) , endocrine gland cancer (en) cuta
Field of study (en)	oncology
Sanadi	Cirrhosis aflatoxins (en)
Symptoms and signs (en)	Shawara, Ciwon ciki, weight loss (en) hepatomegaly (en)
Physical examination (en)	computed tomography (en) , medical ultrasonography (en) , magnetic resonance imaging (en) , endoscopic retrograde cholangiopancreatography (en) , percutaneous transhepatic cholangiography (en) , magnetic resonance cholangiopancreatography (en) , liver biopsy (en) blood test (en)
Medical treatment (en)
Magani	atezolizumab (en) , bevacizumab (en) , sorafenib (en) , lenvatinib (en) , ramucirumab (en) da cabozantinib (en)
Identifier (en)
ICD-10-CM	C22.9 da C22.0
ICD-9-CM	155.0 da 155.2
OMIM	114550
Disease Ontology ID	DOID:3571

Ciwon daji na hanta, wanda kuma aka sani da ciwon hanta, shi ne kansar da ke farawa a cikin hanta.^[1] Ciwon daji wanda ya yadu daga wani wuri zuwa hanta, wanda aka sani da hanta metastasis, ya fi kowa fiye da wanda ke farawa a cikin hanta.^[2] Alamun ciwon daji na hanta na iya hadawa da dunkule ko ciwo a gefen dama a kasan hakarkarin hakarkari, kumburin ciki, fata mai launin rawaya, sauki mai laushi, asarar nauyi da rauni.^[1]

Babban abin da ke haifar da ciwon hanta shine cirrhosis saboda hepatitis B, hepatitis C ko barasa.^[3] Sauran abubuwan da ke haifar da cutar sun hada da aflatoxin, cutar hanta mai kitse ba ta barasa da murar hanta ba.^[2] Mafi yawan nau'o'in ciwon daji na hanta (HCC), wanda ke da kashi 80% na lokuta, da cholangiocarcinoma. Nau'ukan da ba su da yawa sun hada da mucinous cystic neoplasm da intraductal papillary biliary neoplasm.^[2] Ana iya samun goyan bayan ganewar asali ta gwajin jini da hoton likita, tare da tabbatarwa ta hanyar biopsy nama.^[1]

Kokarin rigakafin sun hada da allurar rigakafin cutar hanta ta B da kuma kula da wadanda suka kamu da cutar hanta ta B ko C.^[2] Ana ba da shawarar yin gwaji a cikin masu fama da cutar hanta.^[2] Zabubbukan jiyya na iya hadawa da tiyata, maganin da aka yi niyya da kuma maganin radiation.^[1] A wasu lokuta, ana iya amfani da farfagandar zubar da ciki, maganin kumburin ciki ko dashen hanta.^[1] Ana iya bin kananan kullu a cikin hanta a hankali.^[1]

Ciwon daji na hanta na farko shine na shida a yawan ciwon daji a duniya (6%) kuma na biyun da ke haifar da mutuwa daga cutar kansa (9%).^[2][4] A cikin 2018, ya faru a cikin mutane 841,000 kuma ya yi sanadiyar mutuwar 782,000.^[5] A cikin 2015, mutane 263,000 sun mutu daga cutar kansar hanta ta hanyar hanta, 245,000 ga barasa da 167,000 zuwa hepatitis C.^[6] Yawan ciwon hanta ya fi girma a inda cutar hepatitis B da C ke da yawa, ciki har da Asiya da Afirka kudu da Sahara.^[2] Maza sun fi kamuwa da HCC fiye da mata.^[2] Ganowa ya fi yawa a tsakanin masu shekaru 55 zuwa 65.^[7] Adadin rayuwa na shekaru biyar shine 18.4 % a Amurka,^[7] da 40.4% a Japan.^[8] Kalmar "hepatic" ta fito ne daga kalmar Helenanci hêpar, ma'ana "hanta".^[9]

Ganin cewa akwai dalilai daban-daban na cutar kansar hanta, akwai hanyoyi da yawa don rigakafin cutar kansar hanta. Wadannan yunkurin sun hada da rigakafi da cutar hanta B, maganin hanta, maganin hanta na C, rage yawan amfani da barasa, rage kamuwa da aflatoxin a aikin gona, da kula da kiba da ciwon sukari . Ana ba da shawarar dubawa ga wadanda ke da cututtukan hanta na yau da kullun . Misali, ana ba da shawarar cewa mutanen da ke da ciwon hanta na yau da kullun wadanda ke cikin hadarin kamuwa da cutar sankarar hanta a kowane watanni 6 ta amfani da hoton duban dan tayi.

Domin ciwon hanta laima ce ga nau'ikan ciwon daji da yawa, alamu da alamun sun dogara ne akan irin nau'in ciwon daji. Alamun na iya zama m da fadi. Cholangiocarcinoma yana hade da gumi, jaundice, ciwon ciki, asarar nauyi da haɓaka hanta . ^[9] Cutar sankarau tana hade da ciwon ciki, ciwon ciki, emesis, anemia, ciwon baya, jaundice, itching, asarar nauyi da zazzabi .^[10]

Zabubbukan magani na iya hadawa da tiyata, maganin da aka yi niyya da kuma maganin radiation . A wasu lokuta, ana iya amfani da farfagandar zubar da jini, embolization therapy ko dashen hanta .

1. ↑ ^{1.0 1.1 1.2 1.3 1.4 1.5} "Adult Primary Liver Cancer Treatment (PDQ®)–Patient Version". NCI. 6 July 2016. Archived from the original on 2 October 2016. Retrieved 29 September 2016.
2. ↑ ^{2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7} World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.6. ISBN 978-9283204299.
3. ↑ GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.
4. ↑ World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 1.1. ISBN 978-9283204299.
5. ↑ Bray, F; Ferlay, J; Soerjomataram, I; Siegel, RL; Torre, LA; Jemal, A (November 2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA: A Cancer Journal for Clinicians. 68 (6): 394–424. doi:10.3322/caac.21492. PMID 30207593.
6. ↑ GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
7. ↑ ^{7.0 7.1} "SEER Stat Fact Sheets: Liver and Intrahepatic Bile Duct Cancer". NCI. Archived from the original on 2017-07-28.
8. ↑ "がん診療連携拠点病院等院内がん登録生存率集計：[国立がん研究センター　がん登録・統計]". ganjoho.jp. Retrieved 2 February 2020.
9. ↑ ^{9.0 9.1} "Hepato- Etymology". dictionary.com. Archived from the original on 10 October 2015. Retrieved 24 October 2015.
10. ↑ "Liver tumors in Children". Boston Children's Hospital. Archived from the original on 2011-06-04.